Organon (OGN) Cash from Investing Activities (2020 - 2026)

Organon has reported Cash from Investing Activities for 7 years, with the latest figure at -$76.0 million in Q2 2026.

• Cash from Investing Activities for Q2 2026 came in at -$76.0 million, down 100.0% year-over-year; the trailing twelve-month figure through Jun 2026 was $130.0 million (up 122.38% YoY), and the FY2025 annual result was -$390.0 million, up 23.98% from the prior year.
• Cash from Investing Activities slipped to -$76.0 million in Q2 2026, from $386.0 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $386.0 million in Q1 2026 and troughed at -$296.0 million in Q4 2024.
• A 5-year average of -$70.7 million and a median of -$72.5 million in 2023 frame the typical range for Cash from Investing Activities.
• The widest annual swing landed in 2024, when Cash from Investing Activities tumbled 265.43%; it then soared 324.42% in 2026.
• A 5-year view of Cash from Investing Activities shows it stood at -$61.0 million in 2022, then tumbled by 32.79% to -$81.0 million in 2023, then tumbled by 265.43% to -$296.0 million in 2024, then surged by 78.04% to -$65.0 million in 2025, then retreated by 16.92% to -$76.0 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$76.0 million in Q2 2026, $386.0 million in Q1 2026, and -$65.0 million in Q4 2025.